Rocket Pharmaceuticals
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Option
RITTER DALE officer: Vice President, Finance
 Common Stock 12,500 N/A N/A
Option
RITTER DALE officer: Vice President, Finance
 Restricted Stock Units 12,500 N/A N/A
Purchase
SOUTHWELL DAVID P director
 Common Stock 60,000 N/A N/A
Purchase
CARROLL J MARTIN director
 Common Stock 10,000 N/A N/A
Option
DEVON PARK ASSOCIATES, L.P. 10 percent owner
 Stock Options (Right to Buy) 9,857 N/A N/A
Option
DEVON PARK ASSOCIATES, L.P. 10 percent owner
 Common Stock 9,857 N/A N/A
Purchase
KARABELAS ARGERIS N director, 10 percent owner
 Common Stock 603,832 N/A N/A
Purchase
RHO VENTURES IV QP LP 10 percent owner
 Common Stock 958,226 N/A N/A
Purchase
CARE CAPITAL II LLC 10 percent owner
 Common Stock 603,832 N/A N/A
Purchase
MEDIMMUNE VENTURES, INC. 10 percent owner
 Common Stock 416,667 N/A N/A
Purchase
DEVON PARK BIOVENTURES LP 10 percent owner
 Common Stock 814,166 N/A N/A
Purchase
PITANGO VENTURE CAPITAL PRINCIPALS FUND IV, L.P. 10 percent owner
 Common Stock 212,375 N/A N/A
Purchase
KANTESARIA DEVANG 10 percent owner
 Common Stock 814,166 N/A N/A

Showing 150 to 163 of 163 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.

Similar companies insider trading: